| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(Circulation. 2004;109:2009-2015.)
© 2004 American Heart Association, Inc.
Basic Science Reports |
From the Immunology Research Division and the Vascular Research Division, Department of Pathology (C.B., H.P., Y.U., A.H.S., A.H.L.), and Cardiovascular Division, Department of Medicine (P.L.), Brigham and Womens Hospital and Harvard Medical School, Boston, Mass.
Correspondence to Andrew H. Lichtman, MD, PhD, Department of Pathology, Brigham and Womens Hospital, 77 Avenue Louis Pasteur, Boston, MA 02115. E-mail alichtman{at}rics.bwh.harvard.edu
Received August 22, 2003; de novo received November 3, 2003; revision received January 9, 2004; accepted January 15, 2004.
Background Several lines of evidence indicate that T-cell responses influence the progression of atherosclerotic disease. Interferon-
(IFN-
)producing T cells specific for lesional antigens, including oxidized LDLs and heat shock protein 60 (HSP60), may promote lesion development as well as plaque instability. B7-1 and B7-2 are closely related molecules expressed on antigen-presenting cells that provide costimulatory signals for T-cell activation. This study tested the hypothesis that the ability of T cells to influence atherosclerosis depends on B7-1/B7-2 costimulation.
Methods and Results B7-1/B7-2/LDL receptor (LDLR)deficient mice and LDLR-deficient control mice were fed a 1.25% cholesterol or control diet for 8 and 20 weeks. Total serum cholesterol levels and extent and phenotype of atherosclerosis were analyzed. Splenic and lymph node CD4+ T cells from the animals were cultured with mouse recombinant HSP60 or media and antigen-presenting cells and analyzed for IFN-
and interleukin-4 production. The absence of B7-1 and B7-2 significantly reduced early cholesterol dietinduced atherosclerotic lesion development in LDLR-deficient mice compared with B7-1/B7-2expressing control mice. Furthermore, CD4+ T cells from the cholesterol-fed B7-deficient mice secreted a significantly lower amount of IFN-
in response to mouse HSP60 in vitro than did T cells from B7-expressing control mice.
Conclusions The data show that B7-1 and B7-2 regulated the development of atherosclerotic lesions and the priming of lesional antigenspecific T cells. This study highlights the B7-CD28 pathway as a potentially important target for immunomodulation of atherosclerosis.
Key Words: atherosclerosis immune system cytokines heat-shock proteins T-lymphocytes
This article has been cited by other articles:
![]() |
A. Strom, M. Wigren, A. Hultgardh-Nilsson, A. Saxena, M. F. Gomez, S. Cardell, G. N. Fredrikson, and J. Nilsson Involvement of the CD1d Natural Killer T Cell Pathway in Neointima Formation After Vascular Injury Circ. Res., October 12, 2007; 101(8): e83 - e89. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Kosuge, J.-i. Suzuki, G. Haraguchi, N. Koga, Y. Maejima, M. Inobe, M. Isobe, and T. Uede Critical Role of Inducible Costimulator Signaling in the Development of Arteriosclerosis Arterioscler. Thromb. Vasc. Biol., December 1, 2006; 26(12): 2660 - 2665. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Gotsman, N. Grabie, R. Gupta, R. Dacosta, M. MacConmara, J. Lederer, G. Sukhova, J. L. Witztum, A. H. Sharpe, and A. H. Lichtman Impaired Regulatory T-Cell Response and Enhanced Atherosclerosis in the Absence of Inducible Costimulatory Molecule Circulation, November 7, 2006; 114(19): 2047 - 2055. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.-K. L. Robertson and G. K Hansson T Cells in Atherogenesis: For Better or For Worse? Arterioscler. Thromb. Vasc. Biol., November 1, 2006; 26(11): 2421 - 2432. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. K. Swirski, M. J. Pittet, M. F. Kircher, E. Aikawa, F. A. Jaffer, P. Libby, and R. Weissleder Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease PNAS, July 5, 2006; 103(27): 10340 - 10345. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Isobe, H. Kosuge, and J.-i. Suzuki T Cell Costimulation in the Development of Cardiac Allograft Vasculopathy: Potential Targets for Therapeutic Interventions Arterioscler. Thromb. Vasc. Biol., July 1, 2006; 26(7): 1447 - 1456. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. A. Heller, E. Liu, A. M. Tager, Q. Yuan, A. Y. Lin, N. Ahluwalia, K. Jones, S. L. Koehn, V. M. Lok, E. Aikawa, et al. Chemokine CXCL10 Promotes Atherogenesis by Modulating the Local Balance of Effector and Regulatory T Cells Circulation, May 16, 2006; 113(19): 2301 - 2312. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Galkina, A. Kadl, J. Sanders, D. Varughese, I. J. Sarembock, and K. Ley Lymphocyte recruitment into the aortic wall before and during development of atherosclerosis is partially L-selectin dependent J. Exp. Med., May 15, 2006; 203(5): 1273 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Methe, J.-O. Kim, S. Kofler, M. Weis, M. Nabauer, and J. Koglin Expansion of Circulating Toll-Like Receptor 4-Positive Monocytes in Patients With Acute Coronary Syndrome Circulation, May 24, 2005; 111(20): 2654 - 2661. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Nilsson Regulating Protective Immunity in Atherosclerosis Circ. Res., March 4, 2005; 96(4): 395 - 397. [Full Text] [PDF] |
||||
![]() |
C. Buono, C. J. Binder, G. Stavrakis, J. L. Witztum, L. H. Glimcher, and A. H. Lichtman T-bet deficiency reduces atherosclerosis and alters plaque antigen-specific immune responses PNAS, February 1, 2005; 102(5): 1596 - 1601. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. S. Getz Thematic review series: The Immune System and Atherogenesis. Immune function in atherogenesis J. Lipid Res., January 1, 2005; 46(1): 1 - 10. [Abstract] [Full Text] [PDF] |
||||
|
Circulation Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2004 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |